PSDV - pSivida Limited Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited

PSDV 1.220

+14.0%

Mar 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	11/29/2010 3:17:42 PM
	Read Replies (1) of 421

Biotech Stock Catalysts for December By Brett Chase Nov 29, 2010 1:45 pm Message 26991644 ++++++++++++++++++++++++++++ November 30 Valeant Pharmaceuticals (VRX) and GlaxoSmithKline’s (GSK) epilepsy December 1 Glaxo’s Avodart expanded prostate cancer in some men. December 7 Orexigen Therapeutics (OREX) diet pill Contrave. December 9 Human Genome Sciences (HGSI) and Glaxo’s Benlysta, which would be the first new lupus drug December 10 Cumberland Pharmaceuticals (CPIX) Acetadote for patients with liver failure. December 17 Roche Avastin for breast cancer patients. December 29 MannKind’s (MNKD) inhalable fast-acting insulin product Afrezza. December 30 Endo Pharmaceuticals (ENDP)testosterone gel Fortesta. December 30 Alimera Sciences (ALIM) and pSivida (PSDV), Iluvien ++++++++++++++++++++++++++++

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next